DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

12.39 0.37 (3.08%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VNDA $12.39 3.08%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.02
Previous Close $12.02
Daily Range $11.92 - $12.95
52-Week Range $5.70 - $19.25
Market Cap $419.7M
P/E Ratio -6.64
Dividend (Yield) $0.00 (0.0%)
Volume 631,260
Average Daily Volume 532,149
Current FY EPS -$2.00





Vanda Pharmaceuticals, Inc. (VNDA) Description

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders. Website:

News & Commentary Rss Feed

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

The Wildest Biotech Stock Out There

Vanda Pharmaceuticals (VNDA) Q2 2014 Results - Earnings Call Webcast

3 Small-Cap Biotechs That Institutions Are Loving

Biotech Stock Mailbag: Vanda, Navidea, Provectus

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's "Perilous Reversal" Stock

3 Stocks That Soared Stupendously This Week

A monster week on Wall Street? Definitely -- but these health-care stocks truly sizzled.

Here's What Billionaire John Paulson Has Bought

Might you want to buy into any of these stocks, too?

Vanda Up on EU News - Analyst Blog

Vanda Shares Jumped 29% Amid Continued Success Of Hetlioz

See More VNDA News...

VNDA's Top Competitors

VNDA $12.39 (3.08%)
Current stock: VNDA
GILD $103.84 (-0.88%)
Current stock: GILD
CELG $92.26 (-0.33%)
Current stock: CELG
BIIB $327.58 (0.21%)
Current stock: BIIB